Schechter Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Schechter Investment Advisors, LLC

$997 Million
Q3 2024

A detailed history of Schechter Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 972 shares of REGN stock, worth $717,336. This represents 0.1% of its overall portfolio holdings.

Number of Shares

972

Previous 976 0.41%

Holding current value

$717,336

Previous $1.03 Million 0.39%

% of portfolio

0.1%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $4,096 - $4,807	-4 Reduced 0.41%	972 $1.02 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $7,948 - $9,640	9 Added 0.93%	976 $1.03 Million
Q1 2024 May 06, 2024	SELL	$902.69 - $993.35 $1,805 - $1,986	-2 Reduced 0.21%	967 $930,000
Q4 2023 Jan 17, 2024	SELL	$775.18 - $881.7 $10,077 - $11,462	-13 Reduced 1.32%	969 $851,000
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $17,311 - $21,109	-25 Reduced 2.48%	982 $808,000
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $9,800 - $11,624	-14 Reduced 1.37%	1,007 $723,000
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $43,551 - $52,926	64 Added 6.69%	1,021 $838,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $2,117 - $2,299	-3 Reduced 0.31%	957 $690,000
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $55,675 - $70,259	97 Added 11.24%	960 $662,000
Q2 2022 Nov 03, 2022	BUY	$548.35 - $738.84 $473,226 - $637,618	863 New	863 $510,000
Q1 2022 Nov 18, 2022	SELL	$595.12 - $698.43 $92,243 - $108,256	-155 Reduced 16.15%	805 $563,000
Q4 2021 Dec 27, 2022	SELL	$543.48 - $670.97 $123,913 - $152,981	-228 Reduced 23.75%	732 $463,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.

Account

Schechter Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History